- Home
- KRC vs MMSI Comparison
KRC vs MMSI Comparison
Compare KRC & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KRC | MMSI |
|---|---|---|
| Founded | 1947 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.9B |
| IPO Year | 1997 | 1990 |
Fundamental Metrics
Financial Performance| Metric | KRC | MMSI |
|---|---|---|
| Price | $35.00 | $82.50 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 9 |
| Target Price | $41.33 | ★ $106.22 |
| AVG Volume (30 Days) | ★ 1.9M | 772.2K |
| Earning Date | 02-09-2026 | 02-24-2026 |
| Dividend Yield | ★ 6.30% | N/A |
| EPS Growth | ★ 62.23 | N/A |
| EPS | ★ 2.71 | 1.95 |
| Revenue | $1,126,859,000.00 | ★ $1,477,128,000.00 |
| Revenue This Year | N/A | $13.67 |
| Revenue Next Year | $3.59 | $6.16 |
| P/E Ratio | ★ $12.66 | $40.81 |
| Revenue Growth | 0.77 | ★ 11.41 |
| 52 Week Low | $27.07 | $78.12 |
| 52 Week High | $45.03 | $110.67 |
Technical Indicators
Market Signals| Indicator | KRC | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 30.86 | 43.30 |
| Support Level | $33.82 | $79.22 |
| Resistance Level | $34.76 | $82.28 |
| Average True Range (ATR) | 0.78 | 1.79 |
| MACD | -0.03 | -0.09 |
| Stochastic Oscillator | 22.00 | 30.39 |
Price Performance
Historical ComparisonAbout KRC Kilroy Realty Corporation
Kilroy Realty is a premier owner and landlord of approximately 17 million square feet of office space across Los Angeles, San Diego, the San Francisco Bay Area, Austin, Texas, and greater Seattle. The company operates as a real estate investment trust.
About MMSI Merit Medical Systems Inc.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.